IVERIC Bio
IVERIC Bio is a New York-based biopharmaceutical company that develops and commercializes novel therapies for the treatment of retinal diseases.
Business Model:
Revenue: $210M
Employees: 51-200
Industries / Tags:
Detailed IVERIC Bio Information
IVERIC Bio was acquired by
Astellas Pharma.
The acquisition happend on 2023-04-30.
Details of the transaction were not public
Acquirer
Geographic Data
Address: Five Penn Plaza
City: New York
State: NY
Zip: 10001
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$300M
Raised Total:$808M
Social
Metrics
1,885,696Website Global Rank
11,235Website Monthly Traffic
Twitter Followers
Description
IVERIC Bio is a New York-based biopharmaceutical company that develops and commercializes novel therapies for the treatment of retinal diseases.
Contact Phone:
+12128458200
Contact Email:
IVERIC Bio went public on 9/27/2013 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
9/27/2013
Ticker Symbol:
ISEE
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
